Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use

Details for Australian Patent Application No. 2010238289 (hide)

Owner Astex Therapeutics Limited

Inventors Saxty, Gordon; Berdini, Valerio; Freyne, Eddy Jean Edgard; Papanikos, Alexandra; Benderitter, Pascal; Embrechts, Werner Constant Johan; Wroblowski, Berthold; Akkari, Rhalid

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010238289

PCT Pub. Number WO2010/119284

Priority 0906472.6 15.04.09 GB; 61/169,487 15.04.09 US

Filing date 15 April 2010

Wipo publication date 21 October 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/119284 Priority application(s): WO2010/119284

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010238290-Imidazo [1,2-a]pyridine derivatives as FGFR kinase inhibitors for use in therapy

2010238255-Compositions for immunising against Staphylococcus aerus